Jack Reed sold Emerson Electric Company (NYSE: EMR)
Jack Reed (D-RI), a U.S. Senator, has disclosed 1 trade in Emerson Electric Company (EMR) since 2017, a single sale, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Jack Reed sold $1,001 - $15,000 of Emerson Electric Company (NYSE: EMR) on January 30, 2017. Since that trade, EMR is up +216.67% against the S&P 500 up +277.53%, an outperformance of -60.86%.
Data updated
Jack Reed's EMR trades vs the price
EMR is up +216.67% since Jack Reed sold on January 30, 2017, versus +277.53% for the S&P 500.
Performance since this trade
All Jack Reed EMR trades
Jack Reed & EMR trading FAQ
Is it legal for Jack Reed to trade Emerson Electric Company (EMR) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Emerson Electric Company (EMR), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Jack Reed sell EMR?
Jack Reed disclosed a sale of $1,001 - $15,000 of Emerson Electric Company (EMR) on January 30, 2017, according to public STOCK Act filings.
How has EMR performed since Jack Reed's trade?
Since Jack Reed sold EMR on January 30, 2017, the stock is up +216.67%, versus +277.53% for the S&P 500 over the same period, an outperformance of -60.86%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional EMR trades?
Quantellect tracks every disclosed congressional trade in Emerson Electric Company (EMR) on the Emerson Electric Company congressional trading page, which aggregates filings across all members of Congress.
Jack Reed's EMR tradesAll congressional filings for Emerson Electric CompanyJack Reed's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.